Showing results (11-20 of 98) with videos related to
Sort By:
Pageof 10
Journal of Human Genetics|June 29, 2004
Apolipoprotein E polymorphism is associated with age of onset in schizophreniaOlli Kampman, Sami Anttila, Ari Illi, et al.Journal of Clinical Psychopharmacology|October 2, 2003
Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophreniaAri Illi, Kari M Mattila, Olli Kampman, et al.Neuroscience Letters|August 15, 2009
TPH2 polymorphisms may modify clinical picture in treatment-resistant depressionSami Anttila, Merja Viikki, Kaija Huuhka, et al.Neuroscience Letters|October 22, 2008
Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapyKaija Huuhka, Sami Anttila, Martti Huuhka, et al.The Journal of ECT|March 26, 2005
The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorderMartti Huuhka, Sami Anttila, Esa Leinonen, et al.Neuroreport|November 13, 2004
Neuregulin genotype and medication response in Finnish patients with schizophreniaOlli Kampman, Sami Anttila, Ari Illi, et al.Psychiatric Genetics|June 5, 2003
NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophreniaSami Anttila, Olli Kampman, Ari Illi, et al.Neuroscience Letters|February 22, 2011
P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECTMerja Viikki, Olli Kampman, Sami Anttila, et al.Neuroscience Letters|April 25, 2008
RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorderKaija Huuhka, Olli Kampman, Sami Anttila, et al.Neuroscience Letters|April 27, 2010
Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depressionMerja Viikki, Sami Anttila, Olli Kampman, et al.Pageof 10